Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/023595external-prioritypatent/WO2012109080A1/en
Application filed by Bristol Myers Squibb CofiledCriticalBristol Myers Squibb Co
Publication of TN2013000335A1publicationCriticalpatent/TN2013000335A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The present disclosure relates to compounds of formula I, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
TNP2013000335A2011-03-252013-08-02Hepatitis c virus inhibitors
TN2013000335A1
(en)